Sid Sijbrandij

And that's like a 50-50 of curative.

But there's a reason we have like 10 drugs in the pipeline.

It's where we're

trying to cover all our bases and rather have a jerk too many than one too few.

Yeah, so the mRNA is potentially curative.

So in that case, you're kind of, you're done with this.

But it's certainly like buying time.

You got to have enough treatments to make it to the new development, both science advancing and some of these drugs that I'm developing, they just take years, many years to develop.

So you want to make sure you make it to the next spot and hopefully in as good of a state as you can with like no, hopefully no metastatic cancer, hopefully no fried kidneys.

Yeah, it's a lot of working.

I like working.

These last few weeks I've worked 10-hour days.

A lot of meetings, mostly a whole day's meetings, 25-minute meetings, like 15 a day.

I've also done some traveling for pleasure.

Yeah.

thought at the beginning that this might be my last year so we've uh we celebrated the 25 year anniversary of me and my wife extensively with thank you with friends and family that was great also a lot of traveling like going to medical conferences going to treatments

on multiple continents.

But also doing fun stuff, like adding observability to GitLab.

I started an AI coding company called Kilo.

I'm still creating these companies around open source projects with OpenCore Ventures.